Terms: = Lung cancer AND ZNF521, EHZF, 25925, ENSG00000198795, MGC142208, MGC142182, DKFZp564D0764, Evi3 AND Treatment
1 results:
1. The combination of camrelizumab and apatinib obtained ongoing partial remission for a patient with osimertinib-resistant non-small cell lung cancer: case report.
Cong X; Chen J; Zheng W
Ann Palliat Med; 2021 Mar; 10(3):3469-3474. PubMed ID: 33040541
[TBL] [Abstract] [Full Text] [Related]
